Pituitary adenylate cyclase-activating polypeptide/ vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland

Journal of Molecular Endocrinology

Volumn 16, Issue 3, 1996, Pages 239-248

  Vertongen, P ^a   Delhase, M ^b   Rajas, F ^b   Trouillas, J ^c   Hooghe Peters, E ^b   Svoboda, M ^a   Robberecht, P ^a  

^a Bâtiment G E   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; PROLACTIN; RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GROWTH HORMONE RELEASE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADENYLATE CYCLASE; ANIMALS; CELL LINE; CELL MEMBRANE; DNA PRIMERS; FORSKOLIN; GUANOSINE TRIPHOSPHATE; GUANYLYL IMIDODIPHOSPHATE; KINETICS; NEOPLASM TRANSPLANTATION; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY GLAND; PITUITARY NEOPLASMS; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; REFERENCE VALUES; RNA, MESSENGER; SODIUM FLUORIDE; TRANSCRIPTION, GENETIC;

EID: 0029937049     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0160239     Document Type: Article

References (36)

1. Arimura A 1992 Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regulatory Peptides 37 287-303.
2. Borghi C, Nicosia S, Giachetti A & Said SI 1979 Adenylate cyclase of rat pituitary gland: stimulation by vasoactive intestinal polypeptide (VIP). FEBS Letters 108 403-406.
3. Cauvin A, Robberecht P, De Neef P, Gourlet P, Vandermeers A, Vandermeers-Piret M-C & Christophe J 1991 Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord. Regulatory Peptides 35 161-173.
4. Christophe J 1993 Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochimica et Biophysica Acta 1154 183-199.
5. Ciccarelli E, Vilardaga J-P, De Neef P, Di Paolo E, Waelbroeck M, Bollen A & Robberecht P 1994 Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Regulatory Peptides 54 397-407.
6. Ciccarelli E, Svoboda M, De Neef P, Di Paolo E, Bollen A, Dubeaux C, Vilardaga J-P, Waelbroeck M & Robberecht P 1995 Pharmacological properties of two recombinant splice variants of the PACAP type I receptor transfected and stably expressed in CHO cells. European Journal of Pharmacology 288 259-267.
7. Delhase M, Vergani P, Malur A, Velkeniers B, Teugels E, Trouillas J & Hooghe-Peters EL 1993 Pit-1/GHF-1 expression in pituitary adenomas: further analogy between human adenomas and rat SMtTW tumours. Journal of Molecular Endocrinology 11 129-139.
8. Delhase M, Rajas F, Verdood P, Remy C, Chevallier P, Velkeniers B, Trouillas J & Hooghe-Peters EL 1995 Prolactin and growth hormone mRNA and protein characterization in SMtTW rat pituitary tumours. Journal of Molecular Endocrinology 15 233-243.
9. Gottschall PE, Tatsuno I, Miyata A & Arimura A 1990 Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology 127 272-277.
10. Gourdji D, Bataille D, Vauclin X, Grouselle D, Rosselin G & Tixier-Vidai A 1979 Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6): additive effects of VIP and TRH on PRL release. FEBS Letters 104 165-168.
11. Gourlet P, De Neef P, Woussen-Colle M-C, Vandermeers A, Vandermeers-Piret M-C, Robberecht P & Christophe J 1991 The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphobiastic membranes. Biochimica et Biophysica Acta 1066 245-251.
12. Harmar T & Lutz E 1994 Multiple receptors for PACAP and VIP. Trends in Pharmacological Sciences 15 97-99.
13. Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujn Y, Gonoi T, Miyazaki J-I & Seino S 1994 Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proceedings of the National Academy of Sciences of the USA 91 2679-2683.
14. Ishihara T, Shigemoto R, Mori K, Takahashi K & Nagata S 1992 Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8 811-819.
15. Kato Y, Iwasaki Y, Iwasaki J, Abe H, Yanaihara N & Imura H 1978 Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 103 554-558.
16. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR & Vallar L 1989 GTPase inhibiting mutations activate the α chain of G, and stimulate adenylyl cyclase in human pituitary tumours. Nature 340 692-696.
17. 2-adrenergic receptors. Proceedings of the National Academy of Sciences of the USA 90 10798-10802.
18. Luis J & Said SI 1990 Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines. Peptides 11 1239-1244.
19. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Letters 334 3-8.
20. Nicosia S, Spada A, Borghi C, Cortelazzi L & Giannattasio G 1980 Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase. FEBS Letters 112 139-162.
21. Pisegna JR & Wank SA 1993 Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proceedings of the National Academy of Sciences of the USA 90 6345-6349.
22. Rawlings SR, Piuz I, Schlegel W, Bockaert J & Journot L 1995 Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Endocrinology 136 2088-2098.
23. Robberecht P, Deschodt-Lanckman M, Camus JC, De Neef P, Lambert M S: Christophe J 1979 VIP activation of rat anterior pituitary adenylate cyclase. FEBS Letters 103 229-233.
24. Robberecht P, Waelbroeck M, De Neef P, Tastenoy M, Gourlet P, Cogniaux J & Christophe J 1988 A neu type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts. FEBS Letters 228 351-355.
25. Robberecht P, Woussen-Colle M-C, De Neef P, Gourlet P, Buscail L, Vandermeers A, Vandermeers-Piret M-C & Christophe J 1991 The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP(1-27) and PACAP(1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes. FEBS Letters 286 133-136
26. Robberecht P, Vertongen P, Velkeniers B, De Neef P, Vergani P, Raftopoulos C, Brotchi J, Hooghe-Peters E & Christophe J 1993 Receptors for pituitary adenylate cyclase activating peptides (PACAPS) in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 77 1235-1239.
27. Ruberg M, Rotsztejn WH, Arancibia S, Besson J & Enjalbert A 1978 Stimulation of prolactin release by vasoactive intestinal peptide (VIP). European Journal of Pharmacology 51 319-320.
28. Said SI & Porter JC 1979 Vasoactive intestinal polypeptide: release into hypophysial portal blood. Life Sciences 24 227-230
29. Salomon Y, Londos C & Rodbell M 1974 A highly sensitive adenylate cyclase assay. Analytical Biochemistry 58 541-548.
30. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH & Journot L 1993 Differential signal transduction by five splice variants of the PACAP receptor. Nature 365 170-175
31. Svoboda M, Tastenoy M, Ciccarelli E, Stiévenart M & Christophe J 1993 Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor. Biochemical and Biophysical Research Communications 195 881-888.
32. Svoboda M, Tastenoy M, Van Rampelbergh J, Goossens J-F, De Neef P, Waelbroeck M & Robberecht P 1994 Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochemical and Biophysical Research Communications 205 1617-1624.
33. Trouillas J, Girod C, Claustrat B, Joly-Pharaboz M-O & Chevallier P 1990 Spontaneous prolactin transpiantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma. Cancer Research 50 4081-4086.
34. Trouillas J, Chevallier P, Claustrat B, Hooghe-Peters E, Dubray C, Rousset B & Girod C 1994 Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptint on prolactin secretion and growth of SMtTW pituitary tumors in the rat. Endocrinology 134 401-410.
35. Usdin TB, Bonner TI & Mezey E 1994 Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135 2662-2680.
36. Vertongen P, D'Haens J, Michotte A, Velkeniers B, Van Rampelbergh J, Svoboda M & Robberecht P 1995 Expression of pituitary adenylate cyclase activating polypeptide and receptors in human brain tumors. Peptides 16 713-719.